The Infrastructure Layer for Human-Relevant Medicine

Digital twins, organoids, and AI converge to transform drug discovery under the FDA Modernization Act

MARKET INTELLIGENCE
$0B
TOTAL ADDRESSABLE MARKET
Combined NAMs, Digital Twin & AI Drug Discovery by 2030
Grand View Research, Allied Market Research 2025
0%
DRUG FAILURE RATE
Phase I to approval - the problem NAMs solve
NIH Clinical Development Success Rates
0%
SECTOR CAGR
Fastest-growing life sciences segment 2024-2030
MarketsandMarkets, Frost & Sullivan
FDA 0.0
MODERNIZATION ACT
Eliminates animal testing mandate for drug approval
Active Law
INDUSTRY METRICS
0+
ACTIVE COMPANIES
Organ-on-chip, organoid & digital twin developers
Verified Company Database
$0B
AI DISCOVERY FUNDING
2024 investment in AI-driven drug discovery
PitchBook, Crunchbase
0%
PHARMA ADOPTION
Top 20 pharma using organ-chip technology
IQ MPS Affiliate Survey 2024
0+
ACADEMIC PROGRAMS
Universities with dedicated NAMs research
NIH RePORTER, NSF Awards

Human Simulation Stack

The convergence of biology, computation, and engineering for predictive medicine

Digital Twins

Computational models of individual patients for personalized drug response prediction and treatment optimization.

Organoids

Patient-derived 3D cellular models that replicate organ function for disease modeling and drug testing.

Organ-on-Chip

Microfluidic devices that recreate the physiological environment of human organs for drug safety assessment.

AI-Driven Discovery

Machine learning platforms that accelerate target identification and optimize drug candidates.

The Building Blocks of Life

Real protein structures from the Protein Data Bank powering next-generation drug discovery

Structures courtesy of RCSB Protein Data Bank (rcsb.org) · View Interactive Models

The Patient Analog framework presented here is an original conceptual model developed to organize and contextualize emerging human simulation technologies.

A New Foundation for Human Simulation

A Patient Analog is the unified biological-computational representation of human physiology, integrating organoids, microphysiological systems, organ-on-chip platforms, multi-omics, and simulation engines into a single modeling substrate.

This hierarchy progresses from biological substrates to fully integrated, simulation-ready human models — establishing the foundational infrastructure that will define the next era of drug discovery and precision medicine.

  • The Human The biological reality above all modeling frameworks
  • Patient Analog Integrated bio-digital model of complete human
  • Digital Twin Computational patient simulation platform
  • System Analog Multi-organ physiological subsystems
  • Organ Analog Individual organ modeled at high fidelity
  • Tissue / MPS Engineered microphysiological systems
  • Organoid 3D cell cultures mimicking organ structure
The Human
Patient Analog
Digital Twin
System Analog
Organ Analog
Tissue / MPS
Organoid
Framework aligned with NIH NCATS | FDA NAMs | DARPA MPS | EMA 3Rs

Intelligence Hub

500+ curated research links covering regulatory, scientific, and industry resources

Regulatory

FDA, NIH, EMA guidance and legislation including Modernization Act 2.0/3.0

45+ sources

Scientific

Organ-on-chip, organoids, digital twins, and MPS research platforms

120+ sources

Industry

Leading companies in human simulation technology and drug discovery

85+ sources

AI & Compute

Quantum computing, machine learning, and computational biology resources

50+ sources
LIVE NEWS FEED | Auto-refreshes every 30 min | Last updated: --:--

Explore the Future of Medicine

Interactive simulations, live research feeds, and comprehensive resources for human-relevant drug discovery.

NEXUS 148